new BindingDB logo
myBDB logout

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27326332 66 Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARa Selective Agonist.EBI Bristol-Myers Squibb Company
26990539 79 Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) Agonist.EBI Vitae Pharmaceuticals, Inc.
 61 Synthesis and structure-activity relationships of potent conformationally restricted retinoid X receptor ligandsEBI TBA
 22 Synthesis and receptor binding affinity of conformationally restricted retinoic acid analoguesEBI TBA
 83 Synthesis of highly potent RXR-specific retinoids: The use of a cyclopropyl group as a double bond isostereEBI TBA
 54 Differential RXR & RAR activity of stilbene retinoid analogs bearing thiazole and imidazole carboxylic acidsEBI TBA
19095448 24 Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity.EBI Okayama University Graduate School of Medicine
16364638 99 Aza-retinoids as novel retinoid X receptor-specific agonists.EBI Ligand Pharmaceuticals Inc.
15006411 126 Design, synthesis and structure-activity relationship of novel RXR-selective modulators.EBI Ligand Pharmaceuticals Inc
14592510 150 Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.EBI Ligand Pharmaceuticals Inc
12482435 75 Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.EBI Ligand Pharmaceuticals, Inc.
12161154 11 An improved synthesis of the C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.EBI The Ohio State University
11428923 39 Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.EBI Allergan Inc.
10585206 45 Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.EBI Università di Ferrara
10098670 24 Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.EBI Allergan Inc.
10052980 138 Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.EBI Ligand Pharmaceuticals, Inc
9435893 46 Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.EBI University of Tokyo
8784454 76 Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.EBI Allergan, Inc
8765503 39 Identification of the first retinoid X, receptor homodimer antagonist.EBI Ligand Pharmaceuticals, Inc.
8709094 41 Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.EBI Ligand Pharmaceuticals, Inc.
8308867 72 Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.EBI Ligand Pharmaceuticals, Inc
7650690 64 Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.EBI SRI International